University Of Southern California
Clinical trials sponsored by University Of Southern California, explained in plain language.
-
Bladder cancer drug combo falls short in early trial
Disease control TerminatedThis study tested a combination of two drugs, docetaxel and lapatinib, in 15 people with advanced bladder cancer that had already been treated with chemotherapy. The goal was to see if the combination could slow cancer growth. The trial was terminated early, so results are limite…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Apr 29, 2026 03:40 UTC
-
Home care for the seriously ill: a new approach falls short
Symptom relief TerminatedThis study aimed to see if bringing palliative care to the homes of people with serious illnesses like cancer, heart failure, or lung disease could improve their symptoms and mood. Researchers planned to include over 1,000 patients and their caregivers, but the study was stopped …
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Apr 28, 2026 13:02 UTC
-
Tiny drug particles tested to boost immune attack on head and neck tumors
Knowledge-focused TerminatedThis early study tested a new version of the chemotherapy drug paclitaxel, called FID-007, in one person with head and neck cancer. The drug is wrapped in a special polymer to help it reach deeper into tumors while sparing healthy cells. The goal was to see how it changes immune …
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Apr 29, 2026 03:28 UTC